172 related articles for article (PubMed ID: 614856)
1. Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes.
Kotani S; Kinoshita F; Morisaki I; Shimono T; Okunaga T; Takada H; Tsujimoto M; Watanabe Y; Kato K; Shiba T; Kusumoto S; Okada S
Biken J; 1977 Dec; 20(3-4):95-103. PubMed ID: 614856
[TBL] [Abstract][Full Text] [Related]
2. The effect of replacement of L-alanine residue by glycine, L-serine or D-alanine in an N-acetylmuramyl-L-alanyl-D-isoglutamine on immunoadjuvancies of molecules.
Kotani S; Watanabe Y; Kinoshita F; Morisaki I; Kato K
Biken J; 1977 Jun; 20(2):39-45. PubMed ID: 588232
[TBL] [Abstract][Full Text] [Related]
3. Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.
Kotani S; Watanabe Y; Kinoshita F; Shimono T; Morisaki I
Biken J; 1975 Jun; 18(2):105-11. PubMed ID: 1180867
[TBL] [Abstract][Full Text] [Related]
4. Immunoadjuvant activities of cell walls, their water-soluble fractions and peptidoglycan subunits, prepared from various gram-positive bacteria, and of synthetic n-acetylmuramyl peptides.
Kotani S; Watanabe Y; Shimono T; Narita T; Kato K
Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):302-19. PubMed ID: 126564
[TBL] [Abstract][Full Text] [Related]
5. Immunoadjuvant activities of peptidoglycan subunits from the cell walls of Staphyloccus aureus and Lactobacillus plantarum.
Kotani S; Watanabe Y; Shimono T; Kinoshita F; Narita T
Biken J; 1975 Jun; 18(2):93-103. PubMed ID: 1180873
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs.
Uemiya M; Sugimura K; Kusama T; Saiki I; Yamawaki M; Azuma I; Yamamura Y
Infect Immun; 1979 Apr; 24(1):83-9. PubMed ID: 313372
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
[TBL] [Abstract][Full Text] [Related]
8. Correlation between the immunoadjuvant activities and pyrogenicities of synthetic N-acetylmuramyl-peptides or -amino acids.
Kotani S; Watanabe Y; Shimono T; Harada K; Shiba T
Biken J; 1976 Mar; 19(1):9-13. PubMed ID: 779765
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramylpeptides and bacterial lipopolysaccharides with bovine serum albumin.
Ogawa T; Kotani S; Shimauchi H
Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):19-26. PubMed ID: 3702542
[TBL] [Abstract][Full Text] [Related]
10. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
11. Higher immunoadjuvant activities of N-acetyl-beta-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in comparison with N-acetylmuramyl-L-alanyl-D-isoglutamine.
Tsujimoto M; Kinoshita F; Okunaga T; Kotani S; Kusumoto S; Yamamoto K; Shiba T
Microbiol Immunol; 1979; 23(9):933-6. PubMed ID: 576117
[No Abstract] [Full Text] [Related]
12. Immunoadjuvant activity of synthetic N-acetyl muramyl dipeptide.
Masek K; Zaoral M; Jezek J; Straka R
Experientia; 1978 Oct; 34(10):1363-4. PubMed ID: 738426
[No Abstract] [Full Text] [Related]
13. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil.
Carelli C; Audibert F; Chedid L
Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin.
Ogawa T; Kotani S; Shimauchi H
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: adaptability to various vehicles and pyrogenicity.
Tsujimoto M; Kotani S; Kinoshita F; Kanoh S; Shiba T; Kusumoto S
Infect Immun; 1986 Sep; 53(3):511-6. PubMed ID: 3744548
[TBL] [Abstract][Full Text] [Related]
16. Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.
Chedid L; Carelli C; Audibert F
J Reticuloendothel Soc; 1979 Dec; 26(Suppl):631-41. PubMed ID: 392087
[No Abstract] [Full Text] [Related]
17. Relationship between chemical structure and adjuvant activity of some synthetic analogues of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP).
Audibert F; Chedid L; Lefrancier P; Choay J; Lederer E
Ann Immunol (Paris); 1977; 128C(3):653-61. PubMed ID: 869513
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds.
Azuma I; Sugimura K; Yamawaki M; Uemiya M; Kusumoto S; Okada S; Shiba T; Yamamura Y
Infect Immun; 1978 Jun; 20(3):600-7. PubMed ID: 97234
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.
Azuma I; Okumura H; Saiki I; Kiso M; Hasegawa A; Tanio Y; Yamamura Y
Infect Immun; 1981 Sep; 33(3):834-9. PubMed ID: 7287186
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of the humoral and cellular immune response of guinea pigs after injection of the synthetic adjuvant N-acetylmuramyl L-alanyl-D-isoglutamine: comparison with Freund complete adjuvant.
Souvannavong V; Adam A; Lederer E
Infect Immun; 1978 Mar; 19(3):966-71. PubMed ID: 346491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
